Background-Ion channels are key determinants for the function of excitable cells, but little is known about their role and involvement during cardiac development. Earlier work identified Ca 2ϩ -activated potassium channels of small and intermediate conductance (SKCas) as important regulators of neural stem cell fate. Here we have investigated their impact on the differentiation of pluripotent cells toward the cardiac lineage. Methods and Results-We have applied the SKCa activator 1-ethyl-2-benzimidazolinone on embryonic stem cells and identified this particular ion channel family as a new critical target involved in the generation of cardiac pacemaker-like cells: SKCa activation led to rapid remodeling of the actin cytoskeleton, inhibition of proliferation, induction of differentiation, and diminished teratoma formation. Time-restricted SKCa activation induced cardiac mesoderm and commitment to the cardiac lineage as shown by gene regulation, protein, and functional electrophysiological studies. In addition, the differentiation into cardiomyocytes was modulated in a qualitative fashion, resulting in a strong enrichment of pacemaker-like cells. This was accompanied by induction of the sino-atrial gene program and in parallel by a loss of the chamber-specific myocardium. In addition, SKCa activity induced activation of the Ras-Mek-Erk signaling cascade, a signaling pathway involved in the 1-ethyl-2-benzimidazolinone-induced effects. Conclusions-SKCa activation drives the fate of pluripotent cells toward mesoderm commitment and cardiomyocyte specification, preferentially into nodal-like cardiomyocytes. This provides a novel strategy for the enrichment of cardiomyocytes and in particular, the generation of a specific subtype of cardiomyocytes, pacemaker-like cells, without genetic modification. (Circulation. 2010;122:1823-1836.)
study we identified SK channel activity to be responsible for cytoskeleton reorganization in neural progenitors. 3 SKCa activity, in particular via SK3, plays also an important role during early neural morphogenesis (S.L. et al, unpublished data). As SKCas are widely distributed in the organism, we used pluripotent embryonic stem (ES) cells as a bona fide embryonic development model to explore their potential modulation of cell lineage commitment, differentiation, and spatialization. 4 -6 We were particularly interested in cardiac development because SKCas are differentially expressed in the cardiac system. [7] [8] [9] These channels are found predominantly in the atrium, the atrioventricular node, and pulmonary veins, 8 -10 where they are involved in the regulation of the action potential (AP) duration. 11 In particular, SK4 has been described in atrial stretch-induced atrial natriuretic factor secretion 12 and abbreviation of the AP duration in pulmonary vein myocardium 10 and represents the solely upregulated SK isoform in the developing atrioventricular node. 13 In addition, SK4 was found to be the only SK subtype being upregulated during regeneration/remodeling in a rodent model of myocardial infarction. 14 Herein we report a major role for SK4 in cardiac subtype differentiation from ES cells. This is a novel and efficient approach for the generation of specific cardiac subtypes (ie, pacemaker-like cells) for pharmaco-toxicological studies and for future regenerative medicine without modifying the stem cell genome.
Methods

ES Cell Culture
Feeder-free murine embryonic stem cell lines CGR8 15 and 46C 15 were cultivated according to standard conditions. 16 
Differentiation of ES Cells
In vitro differentiation of ES cells was carried out according to the standard protocol using the hanging drop method as described. 16 In addition, experimental outlines are given in the respective figures.
Dye-Dependent Membrane Potential Measurement
CGR8 cells were loaded with 2 mol/L of Di-8-ANEPPS dye (Invitrogen) for 25 minutes and then washed twice with tyrode solution. For the excitation of the dye, the argon laser was used at 488 nm. The emission light was measured in 2 spectral bands: band pass filter (BP): 530 to 600 nm; low pass filter (LP): from 615 nm. The ratio signal was calculated as:
Ratio signalϭ
BPϪsignal LPϪsignal EBIO induces a hyperpolarization of the ES cell membrane potential as illustrated by the decreased ratio value, as the emission spectrum of the dye is blue shifted by a potential increase in the immediate proximity.
Patch-Clamp Experiments
Patch-clamp experiments were performed as previously described. 17 For a detailed protocol, please refer to the online-only Data Supplement Methods.
Proliferation Assay
Cell proliferation assays were performed using the CellTiter-Glo Luminescent Cell Viability Assay (Promega, Madison, Wis) according to the manufacturer's protocol.
Quantitative PCR
Quantitative 1-step real-time reverse transcriptase polymerase chain reaction (qPCR) analysis was done as previously described. 3, 16 Details are described in the online-only Data Supplement Methods.
Immunocytochemical Analysis and Immunoblotting
Immunofluorescence and immunoblotting were carried out using standard techniques. Detailed conditions are described in the onlineonly Data Supplement Methods. Nuclei were stained with 4Ј,6diamidino-2-phenylindole in blue color.
Treatment Regimes
Schematic outlines of the experimental course of each experiment are shown in the figures. For EBIO treatment, a 1-mol/L stock solution was prepared in sterile dimethyl sulfoxide, and cells were treated at final concentration of 1 mmol/L. EBIO was used throughout the study in that concentration. EBIO was added to the culture medium every second day, with regular medium changes. Dimethyl sulfoxide served as a solvent control.
Statistical Analysis
If not stated otherwise, SEM are indicated by error bars. For comparisons of 2 groups, levels of significance were calculated with the unpaired Student t test. For comparisons across Ն3 groups, 1-way ANOVA with a Bonferroni post hoc test was applied, and levels of significance were illustrated by asterisks: Ͻ0.001,***; 0.001 to 0.01, **; 0.01 to 0.05, *. The Fisher exact test was used for comparisons of binary outcomes, and probability values are indicated by crosses (#) and represent PϽ0.0001. Calculations of significance were done with GraphPad Prism 5 (GraphPad Software Inc, San Diego, Calif). Generalized estimating equations models were used for analysis of repeated measurements, and probability values are indicated by § and represent PϽ0.0001. This was done as an advance model for analysis of repeated measurements using the R-software.
Results
ES Cells and Their Differentiated Progenies Express All SKCa Subtypes
We identified SKCa subtypes in ES cells at mRNA level using qPCR. The dominant SKCa transcript was SK4, followed by SK2, SK3, and SK1 in 2 independent ES cell lines (CGR8 and 46C) ( Figure 1A and 1B). ES cells were induced to differentiate in embryoid body (EB) assays, and transcript levels of SKCas were investigated at different stages of EB formation. We found differentially regulated expression patterns of all SKCas with different kinetics for SK1-4 ( Figure  1C Figure 1K ). This process was dose-dependent, with a maximal activity at 1 mmol/L ( Figure 1L ). Next, we aimed to block EBIOinduced hyperpolarization by either apamin (inhibitor for Sk1-3) or clotrimazole (inhibitor for SK4). 1 Apamin decreased the hyperpolarization effect by 60%, whereas clotrimazole decreased it by 70% (online-only Data Supplement Figure IK ).
SKCa Activation Leads to Reduced ES Cell Proliferation
SKCa subtypes are involved in growth regulation. 18, 19 We therefore performed proliferation assays in response to SKCa activation and found a reduced proliferation in both ES cell lines tested (Figure 2A and online-only Data Supplement Figure IIA ). ES cells are characterized by a specific cell cycle pattern with few cells in G 1 and G 2 , but a high proportion of cells in the S phase. 20 SKCa activation resulted in a significant reduction of cells in S (65% versus 43%) and a corresponding increase in G 1 but also G 2 /M phase (26% versus 38%, 10% versus 18%; Figure 2B and 2C). SKCa activation was followed by downregulation of cyclin E and an increase in Rb phosphorylation, indicating a reactivated G 1 -S checkpoint ( Figure 2D and 2E). In addition, cyclin D3, which is usually downregulated in differentiating ES cells, 21 was reduced in the EBIO-treated ES cells ( Figure 2F ). ␤-actin served as a loading control ( Figure 2G ). Reduced proliferation was not accompanied by enhanced apoptosis shown by fluorescent activated cell sorting analysis with 7-AAD and AnnexinV ( Figure 2H through 2J and online-only Data Supplement Figure IIB ). This was further confirmed by a lack of cleaved caspase 3 in EBIO-treated cells (online-only Data Supplement Figure IIC ). Thus EBIO treatment caused ES cells to cease proliferation and to undergo differentiation.
SKCa Activation Alters the Cytoskeleton and Activates Differentiation of ES Cells
We previously demonstrated that enhanced SKCa activity induced formation and elongation of filopodia in neural progenitor cells. 3 Similar effects were observed in ES cells. Short-term SKCa activation for 2 hours altered membrane morphology by formation of multiple filopodia-like protrusions without changes in the ES cell colony phenotype ( Figure 3A and 3B, arrows, insert). Long-term SKCa activation for 3 days ( Figure 3C ) strongly altered the morphology of ES cells (decreased cellular connectivity, increased size, polygonal shape) suggesting ongoing differentiation ( Figure 3D and 3E and online-only Data Supplement Movie I). This suggestion was further supported by loss of the pluripotency markers Oct4, Sox2, Rex-1, Nanog, and the stem cell factor c-Kit at mRNA level on EBIO treatment ( Figure 3F ). This was confirmed at the protein level by immunostaining for Oct4 and SSEA1 in 3 independent cell lines. Both proteins were diminished under EBIO incubation ( Figure 3E and data not shown). The cell morphology after long-term SKCa activation displayed long filopodia and an increase in F-actin, suggesting a primitive mesodermal cell type ( Figure 3E ).
Next we sought to characterize in more detail the changes occurring in the ES cells on SKCa activation by employing microarray transcriptome analysis after 3 days of monolayer culture (according to scheme in Figure 3A and online-only Data Supplement Figure 3A through 3D). In particular we wanted to determine whether EBIO treatment induced differentiation toward the mesodermal lineage. We found that EBIO treatment consistently changed the expression of Ϸ2400 genes as depicted in heat map format (online-only Data Supplement Figure IIIA ). To position EBIO-treated ES cells in mesodermal differentiation, we used a series of consecutive microarray data sets of ES cells that were induced to mesodermal differentiation and further into cardiomyocytes. 22 Principal components analysis placed EBIOtreated ES cells between the expression pattern of ES cells at days 3 and 7 of mesodermal induction (online-only Data Supplement Figure IIIC ). This was further underlined by hierarchical clustering analysis showing that EBIO-treated cells cluster closer to day 7 cardiac bodies than control cultures (online-only Data Supplement Figure IIID) . Among other genes, 5T4, a glycoprotein expressed during early ES cell differentiation, 23 was upregulated, as well as early mesoderm-specific (Gata2, Gata3, and BMP2 24,25 ) genes. Striated muscle structural proteins such as tropomyosins, myosin light chain proteins, and ␣ smooth muscle actin were also induced, whereas Pax6, involved in ectoderm development, was downregulated (online-only Data Supplement Figure IIIB and IIIE). Because our transcriptome analyses represented only a temporal snapshot, we aimed to dissect the developmental program in a time-dependent manner by focusing on early cardiac genes. We found an upregulation of the early mesoderm marker brachyury, 26 similarly of the early cardiac marker genes Mesp1 27 and Nkx2.5. 28 Subsequently, Isl1, marking the secondary heart field and early cardiac progenitors together with Flk1, 29 peaked as early as 24 hours after SKCa activation, and Flk1 was further upregulated during ongoing differentiation. Additionally, the homeobox transcription factor Tbx3 30 that plays a key role in fate determination of the conduction system was increased within 120 hours of differentiation ( Figure 3G ).
To exclude off-target effects, we investigated the dose dependency of EBIO and 2 other SKCa enhancers, namely DC-EBIO and riluzole. Increasing EBIO concentrations resulted in decreasing Oct4 transcript levels (online-only Data Supplement Figure IVA) . The half-maximal effect was obtained at 0.1 mmol/L, corresponding to its described EC 50 value on SKCa activation. 1 Maximal effects were obtained at a concentration of 1 mmol/L. DC-EBIO and riluzole similarly decreased Oct4 levels (online-only Data Supplement Figure IVB) .
To corroborate the strong differentiation capacity of EBIO in the ES cells, we performed teratoma formation experiments in immune-deficient mice, a sensitive assay for the existence of residual pluripotent cells. Our experiments clearly demonstrated that teratoma formation was almost completely absent and further mirror the dramatic and fast downregulation of pluripotency genes on activation of SKCas (online-only Data Supplement Figure VA through VE). 
SKCa Activation in ES Cells Induces Cardiac Differentiation
Because of the upregulation of mesodermal and early cardiac genes, we tested the effects of SKCa activation in the in vitro cardiac differentiation assay based on the formation of multicellular EBs in the presence of EBIO ( Figure 4A ). Using this differentiation protocol we identified enhanced cardiogenesis based on upregulation of Mesp1, Isl1, Flk1, and Nkx2.5 genes on SKCa activation ( Figure 4B ). We also detected downregulation of ventricular marker genes (Cx43, Myl2v; online-only Data Supplement Figure VII and VIJ), whereas atrial-specific genes such as Myh6 28, 31 and Myl2a were strongly upregulated ( Figure 4B and online-only Data Supplement Figure VIH) . Although it is well-established that Gata4 directs development of cardiac-inducing endoderm from ES cells, we did not find induction of Gata4 transcripts. However, development of the secondary heart field including the sino-atrial node (SAN) is not dependent on Gata4 expression 32 (online-only Data Supplement Figure VIE) .
Investigating the expression of cardiac proteins, we found a sarcomere-specific labeling by myosin heavy chain ( Figure  4C and 4D) and the Z-band epitope of titin both in control and EBIO-treated variants (online-only Data Supplement Figure  6A and 6B). In contrast to control cells, EBIO treatment resulted in a highly enriched cardiac population. Skeletal muscle cells were exclusively found in control variants (white arrow in Figure 4C Figure VIC) .
At the end of a 10-day treatment period ( Figure 4A ), we found relatively large, spontaneously beating areas (onlineonly Data Supplement Movie II). Myosin heavy chain and Titin were used to characterize cardiomyocytes 3 and 7 days after EBIO removal. The area of beating foci increased with time ( Figure 4D and online-only Data Supplement Figure VIB ). Immunocytochemical analysis of dissociated and replated cells revealed an enrichment by approxi- mately 4 times of ␣-actinin positive cells in EBIO-treated compared with control cells (65% versus 15%; Figure 4E ). This was substantiated in cardiac troponin-based flow cytometry assays (58.6% versus 11.2%; Figure 4F and 4G). Electron microscopy revealed a well-distributed sarcomeric apparatus ( Figure 4H ).
Alternative SKCa-activating compounds showed comparable results: both riluzole and DC-EBIO induced cardiomyocyte differentiation, as shown by qPCR for Myh6 mRNA (online-only Data Supplement Figure IVC ).
SKCa Activation Induces Functional Pacemaker-Like Cells
Most of the cardiac clusters that arose on SKCa activation displayed strong fluctuations in their interbeat intervals suggestive of high numbers of cardiac pacemaker-like cells (online-only Data Supplement Movie II). HCN4, a member of the family of channels responsible for the hyperpolarization activated current, I f , plays a major role in the pacemaker potential of the SAN. It labels pacemaker tissues, including the SAN; serves as an excellent nodal marker; and was predominantly expressed in EBIO-treated cultures. Cultures were treated according to Figure 5A . The SAN development is driven by a gene expression program involving Tbx2, Tbx5, Shox2, and Tbx3, finally leading to the expression of Hcn4, Isl1, 30 and the low-conductance connexins (Cx30.2 and Cx45). 30 qPCR analyses after SKCa activation showed significant upregulation of all these pacemaker marker genes ( Figure 5B and online-only Data Supplement Figure 6F ). Immunostaining revealed that almost two thirds of the EBIOinduced cardiomyocytes were double-positive for HCN4 and titin ( Figure 5C and 5D ). HCN4 showed predominant membrane distribution ( Figure 5E and online-only Data Supplement Movie III). For a quantitative analysis of this finding, we dissociated EBs, replated cells at low density, and performed immunocytochemistry. By counting HCN4/␣actinin coexpressing cardiomyocytes, we found a significant increase in double-positive cells in EBIO-treated compared with control cells, with the typical membrane localization of HCN4 in these cardiomyocytes (60% versus 13%; Figure 5D and 5E). Connexin 30.2 was also strongly abundant at the protein level in EBIO-treated cultures ( Figure 5F and 5G) . The arising cell type mostly showed less myofibrillar content ( Figure 5E and 5G) and was significantly smaller 33 (Figure 5H) .
To specify the cellular phenotype, we performed transcriptome analysis of EBIO-derived cells on day 10 after EB plating (online-only Data Supplement Figure VIIIA through VIIID). Principal components analysis showed clustering of EBIO-treated cells at proximity of murine postnatal cardiomyocytes and heart tissue (online-only Data Supplement Figure VIIIA ). This was further underlined by a hierarchical clustering analysis (online-only Data Supplement Figure  VIIIB) . Specific genes typically expressed in the developing heart and terminally differentiated cardiomyocytes were similarly expressed in EBIO-treated cultures (online-only Data Supplement Figure VIIIC ). In addition, we selected a set of genes previously shown to be suitable as a fingerprint for the SAN and the developing conduction system. 34, 35 These genes are either enriched or downregulated in the SAN in comparison with the working myocardium (atrium, ventricle). SKCa activation induced an expression pattern resembling the SAN (online-only Data Supplement Figure VIIID ).
Characterization of Control and EBIO-Treated ES Cell-Derived Cardiomyocytes
As a functional proof that the application of EBIO directs the differentiation of ES cells into mainly pacemaker-like cardiomyocytes, we performed patch clamp experiments. In the untreated control group (nϭ28) we measured APs of all 3 major cardiomyocyte subtypes, namely pacemaker-like (7.2%), atrial-like (7.2%), and ventricular-like (85.7%) cells. In EBIO-treated cardiomyocytes (nϭ38), all 3 cell types could also be identified ( Figure 6A ). However, the majority (57.8%) of the EBIO-treated cardiomyocytes displayed pacemaker-like APs, and only lower percentages of atrial-like (21.05%) and ventricular-like (21.05%) cells were found ( Figure 6A ). Some cardiomyocytes in the control (nϭ3) and in the EBIO-treated (nϭ2) groups had AP characteristics, which did not fit with any of the above-mentioned subtypes and were therefore considered "not defined" and excluded from the statistical analysis. Our data demonstrate that cardiomyocytes with pacemaker-like APs are approximately 7 to 8 times enriched in cells of EBIO-treated EBs compared with controls. This is in good agreement with the increased number of HCN4-expressing cells mentioned above. In addition, we analyzed the key physiological parameters of AP shape and duration, such as maximum diastolic potential and AP duration at 90%, 70%, and 50% of repolarization. The data illustrate that the AP duration tends to be shorter in all subtypes of EBIO-treated cardiomyocytes; this was significant for the ventricular-like cells (for AP duration at 90%: control, 64.4Ϯ3.1 ms versus EBIO, 99.8Ϯ7.3 ms, PϽ0.0001; online-only Data Supplement Table I ).
We also assessed the functional integrity of the cells. For this purpose the hormonal regulation of chronotropy was investigated. As previously reported for early-stage ES cell-derived cardiomyocytes, 36 application of the acetylcholine analog carbachol (CCh, 1 mol/L) induced a prominent negative chronotropic effect. As shown in Figure 6B and 6C, APs came to an abrupt halt in the large majority of control (82.4%, nϭ17) and in all of the EBIO-treated (100%, nϭ17) ES cell-derived cardiomyocytes on application of CCh. Only in 17.6% of both, control and EBIO-treated cells, CCh application led to hyperpolarization (3.5Ϯ0.1 mV in control, nϭ3; and 7.3Ϯ0.2 mV in EBIO-treated cells, nϭ3; Figure  6C ). These data clearly demonstrate that control and EBIOtreated ES cell-derived cardiomyocytes are functionally intact and that these cells display typical features of the hormonal regulation of chronotropy reminiscent of early differentiation stages of cardiomyocytes. 36 We investigated the functional expression of I f as a prominent HCN4 transcript ( Figure 5B ), and its expression was observed particularly in the EBIO-treated cardiomyocytes ( Figure 5C through  5E ). I f could be recorded from both control (nϭ3) and EBIO-treated (nϭ8) ES cell-derived cardiomyocytes displaying normal biophysical characteristics ( Figure 6D ). None of the ventricular-like cells of the EBIO-treated (nϭ4) and control group (nϭ5) displayed I f , whereas atrial-like (7.5Ϯ1.7 pA/pF, nϭ4) and nodal-like cells (9.4Ϯ2.8 pA/pF, nϭ4) of the EBIO group displayed prominent I f . Thus these functional findings are fully correlated with the prominent HCN4 protein expression found in EBIO-treated EBs. Our results also demonstrate that EBIO induces a prominent subtype specification of ES cells into pacemaker-like cells.
SK4 Knock-Down Prevents SKCa-Mediated Cardiac Differentiation
To verify the effects of SKCa modulation and to identify the SKCa subtype responsible for cardiac induction, we blocked EBIO effects by coincubation with either apamin or clotrimazole ( Figure 7A) . In contrast to apamin, the SK4 inhibitor clotrimazole diminished EBIO-induced cardiogenesis and pacemaker transcript upregulation ( Figure 7B and 7C) . As a more specific approach, we chose specific small hairpin RNAs (shRNAs) to dissect the contribution of distinct SKCa subtypes to the differentiation process ( Figure 7D ). All SK subtypes were knocked down by transient RNA interference in ES cells. Reduced protein levels were verified by immunocytochemistry (online-only Data Supplement Figure  VIIA) . SK4 knock-down was further confirmed by immunoblotting (online-only Data Supplement Figure VIIB) . Cells transfected with RNA interference constructs against all 4 channels or SK4 alone showed a marked inhibition of Oct4 suppression. However, individual SK1, SK2, or SK3 knockdown did not alter EBIO-induced downregulation of Oct4 ( Figure 7E) . These experiments suggested that SK4 plays the predominant role. Therefore we used 3 independent SK4 knock-down ES cell lines (SK4 shRNA1, 2, and 1ϩ2, to exclude random insertion bias) engineered via lentiviral shRNA delivery (online-only Data Supplement Figure VIIC and VIID) and examined cardiac pacemaker differentiation. The cells were differentiated in a spontaneous differentiation protocol according to Figure 7F . In all 3 cell lines beating clusters were absent ( Figure 7G ). Strong downregulation of cardiac and pacemaker transcripts supported this observation ( Figure 7H through 7J ).
SKCa Activation Leads to Increased ERK1/2 Signaling
The ERK1/2 signaling cascade is a key regulator linking extracellular stimuli to proliferation, differentiation, and survival. It is also an auto-inductive stimulus for uncommitted ES cells to exit self-renewal 37 and regulates mesodermal development. 38 SKCa activation rapidly induced p44/42 ac-tivation both in undifferentiated ES cells ( Figure 8A ) and EBs ( Figure 8E ). Increased ERK1/2 phosphorylation was detectable after 60 minutes, reaching a plateau at 120 minutes of induction ( Figure 8A ). This effect could be abolished via inhibition of MEK1/2 using selective MEK inhibitors PD98059 (not shown) or UO126 ( Figure 8B) . One of the best known upstream activators of ERK1/2 is the Ras-Raf-MEK1/2 pathway. 39 To analyze whether Ras is also activated by EBIO, Ras activity assays were performed ( Figure 8F) , demonstrating that the Ras-GTP level was already slightly enhanced after 20 minutes and markedly enhanced after 60 minutes of stimulation, reaching a maximum within 3 hours. To investigate whether activation of the ERK1/2 cascade was required for EBIO-induced cardiac differentiation, we examined the effect of PD98059 or UO126. Both inhibitors prevented cardiac differentiation as demonstrated by the expression of Myh6 ( Figure 8H ) as well as pacemaker generation, as indicated by the expression of Hcn4 and Cx30.2 (Figure 8I and 8J) at day 10 EBs. This reflects a signaling cascade comprising SKCa3 Ras3 Mek1/ 23 ERK1/2 that could be required for cardiac differentiation of ES cells upon SKCa activation.
Discussion
We investigated the role of SKCas in ES cells and found a novel function, in particular for SK4, as physiological mod-ulators of cardiac differentiation and subtype specification. We show that SKCas are expressed at mRNA and protein levels. Additionally, SKCas induced, on activation, hyperpolarization of the membrane potential in undifferentiated ES cells. This is in line with earlier findings of SKCa currents in murine ES cells. 40 Although SKCa currents could not be recorded in human pluripotent cells so far, 41 all SK channel isoforms are readily detected in human ES and iPS cells, with a high expression of SK4 (GEO id GSE9071). Because all subtypes are expressed in human pluripotent cells, future experiments must finally clarify the functional role of this particular ion channel family in the human system.
The impact of SKCas on regulating ES cell differentiation was supported by our observation that SKCa activation inhibits cell proliferation, an event typically accompanying initiation of cell differentiation. Monolayer differentiation of EBIO-treated ES cells revealed upregulated genes associated with heart development and downregulated pluripotency and neuroectodermal markers. Most interestingly, accelerated and enhanced cardiac-specific transcript expression as well as early pacemaker genes (Tbx3) were detected. The ultimate proof for the generation of cardiac cells, however, was obtained in the EB system. SKCa activation induced a strong enhancement of cardiac lineage commitment. qPCR, quantitative immunostaining, and fluorescent activated cell sorting analysis proved an increase in the absolute number of cardiomyocytes after SKCa activation. A prominent cardiac subtype specification into pacemaker-like cells was detected at the transcript level. HCN4 and Connexin30.2 labeling, as Figure 8 . The signaling axis SKCa-Ras-Mek1/2-ERK1/2 is activated in ES cells and their differentiated progeny and is required for cardiac lineage commitment after SKCa activation. A, CGR8 cells were stimulated for the time indicated with EBIO and analyzed for either phosphorylated ERK (p-ERK) and ␤-actin by Western blot analysis (nϭ4). B, As described in A, CGR8 cells were stimulated with EBIO and preincubated for 12 hours with UO126 (10 mol/L) as indicated in the figure. Representative immunoblots are shown (nϭ3). C, Quantification of band density relative to ␤-actin is shown for 120-minute stimulation with EBIO in CGR8 cells (nϭ3). D, CGR8 cells were stimulated for 120 minutes with EBIO and stained for p-ERK (red; identical exposure times; nϭ2). E, Day 6 EBs were stimulated according to A with EBIO. Representative immunoblots for p-ERK and with corresponding ␤-actin are shown (nϭ2). F, CGR8 cells were stimulated for the time indicated with EBIO and analyzed for either Ras-GTP or total-Ras (nϭ3). G through I, ERK inhibition blocks cardiac and pacemaker cell differentiation on SKCa activation. qPCR analysis of Myh6 (G), Hcn4 (H), and Connexin 30.2 (I) mRNA levels 10 days after plating in the presence (ϩ) or absence (-) of EBIO, PD98059 (25 mol/L), or UO126 (10 mol/L). Three independent experiments, each performed in triplicates with CGR8 cells. Significance was calculated by ANOVA test (indicated by asterisks).
well as quantitative electrophysiological studies, confirmed prominent enrichment of functional pacemaker-like cells. It is noteworthy that the clear nodal-like switch in the electrophysiological pattern was correlated entirely with the quantitative HCN4 staining data. Further evidence for the pacemaker-like phenotype and the strong cardiac enrichment of EBIO-treated cultures was given by whole transcriptome analyses. SKCa activity induced cellular clustering with postnatal cardiomyocytes and heart tissue. Furthermore, a gene set known to separate different cardiac subtypes clearly identified EBIOtreated cultures as being enriched for pacemaker-like cells.
It is well accepted that differentiating ES cells do not represent pure and mature functional tissue, which biases transcript level analysis by other cell populations also expressing the respective marker gene. However, in EBIOtreated cells we reach a high purity of a particular cell type that allows reliable data already at the transcription profile. The functional role of SKCa channels in the mature heart has been a matter of debate, and efforts to elucidate their developmental role are rather limited. However, recent data from in vivo models clearly underline that ion channels play a crucial role during cardiac development. 42, 43 In this study we identified SK4 as the important SKCa channel subtype for the described mechanisms. This is in line with transcriptional analysis showing 9-fold upregulation of SK4 in the developing conduction system compared with SK1-3. 13 A conduction system phenotype of the SK4 null mouse has not been reported. However, detailed analyses, as performed for the SK2 null mouse (displaying severe changes in APs of the atrioventricular node), are lacking. 11 In addition, compensatory mechanisms might apply differently for both in vitro and in vivo situations. 44, 45 Nevertheless, the lack of cardiac differentiation in our SK4 knock-down ES cell lines points to a fundamental developmental role of this particular channel, at least under conditions of in vitro ES cell differentiation. The generation of pacemaker cells in vitro provides a powerful tool for direct cell manipulations, strategies for genetical engineering, or functional measurements such as electrophysiological analysis of arising cardiomyocytes. Additionally it might be used as a tool for pharmaceutical and toxicological screens.
Downstream of SKCa activation, we demonstrate an intracellular signaling pathway linking SKCa activation to ERK1/2 signaling, which subsequently leads to cardiac commitment and functional pacemaker cell differentiation. In particular, SK4 is known to signal via this specific pathway. 46 This notion is supported by the fact that ERK2 -/-ES cells and embryos fail to induce mesoderm. 38 Similarly, we investigated ERK2 -/-ES cells and found them to be nonresponsive to SKCa activation (data not shown). SKCa activity may not directly initiate ERK1/2 signaling, but Ras activation and ERK1/2 phosphorylation is induced during the described process. The finding of similar activation kinetics in ES cells and in differentiated EBs where self-renewal is no longer important points to the relevance of ERK1/2 activation. Future analysis of this most likely multifactorial signaling pathway is warranted to identify additional components.
It is well-accepted that ES cells represent a particularly attractive source for ex vivo generation of cardiomyo-cytes. 47, 48 Considering the feasibility of cell therapy, major obstacles need to be overcome, such as improvement of (1) contractile heart function, (2) prevention of arrhythmias caused by insufficient graft guidance, (3) potential teratoma formation, 49 and (4) immunotolerance. Here we provide a new cardiac differentiation system exclusive of genetic manipulation and lineage selection and thus fulfilling most of these criteria.
In summary, our data allow 3 major conclusions: First, the SK ion channel family plays a pivotal role in ES cell differentiation and illustrates ion channels as important players in the regulation of developmental processes. Second, SKCa activation in ES cells induces efficient and rapid cardiac lineage induction with an efficient elimination of residual pluripotent cells. Third, the cardiomyocytes contain a high yield of functional pacemaker-like cells. Therefore, modulation of ion channel activity establishes a new noninvasive strategy to enhance cardiac differentiation. Indeed, the present study for the first time identifies the functional relevance of a specific ion channel for the differentiation of ES cells into cardiac pacemaker-like cells. The differentiation system presented here provides an interesting tool for applications in biomedical engineering, pharmaco-toxicology, and even potential therapeutic applications.
